US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Chikungunya

Recent news which mentions Chikungunya

Read Why Valneva's Stock Gained 7% Today
Tickers VALN
Tags VALN General Small Cap
From Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
Tickers VALN
Tags VALN Small Cap General
From Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
Tickers MRNA
Tags Chikungunya Trading Ideas Health Care
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Tickers VALN
Tags Benzinga News FDA
From Benzinga